Related Experiment Video
Updated: Jun 22, 2026
03:53
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
A neglected problem of developing countries: Noncystic fibrosis bronchiectasis
Arzu Babayigit1, Duygu Olmez, Nevin Uzuner
1Department of Pediatric Allergy, Dokuz Eylul University Medical School, Balcova, 35340, Izmir, Turkey. arbabayigit@yahoo.com
Annals of Thoracic Medicine
|June 30, 2009
Summary
This study identified common causes of non-cystic fibrosis bronchiectasis in children, finding infections and asthma most frequent. Identifying the etiology is key for effective management and reducing complications.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
Background:
- Bronchiectasis, defined as permanent bronchial dilation, remains a significant health issue, particularly in developing nations.
- Non-cystic fibrosis bronchiectasis (NCFB) in children presents unique diagnostic and management challenges.
Purpose of the Study:
- To characterize children diagnosed with NCFB.
- To determine the underlying etiological factors contributing to NCFB in pediatric patients.
Main Methods:
- Retrospective analysis of 66 children (1-17 years) with NCFB confirmed by high-resolution computed tomography.
- Data collection included clinical symptoms, onset age, physical examination, laboratory findings, identified etiologies, and treatment modalities.
Main Results:
- The most common symptoms were cough (100%) and sputum production (50%).
- An underlying cause was identified in 66.7% of cases.
- Top etiologies included infections (21.2%), asthma (16.7%), aspiration/GERD (9.1%), and immunodeficiency (7.6%).
Conclusions:
- Establishing the etiology of NCFB is crucial for guiding patient management.
- Identifying the cause can potentially reduce the incidence, progression, and complications of bronchiectasis.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...